Français | Home | Contact | Links

The strength of the Canadian Arthritis Network is in its partnerships with consumers, academics, clinicians, voluntary agencies, industry and government. These partnerships are an essential element in achieving the Network's vision of a world free of arthritis.

Alliance for the Canadian Arthritis Program

The success of the inaugural OA Consensus Conference in 2002, along with the need to lobby the federal government to take action on arthritis, prompted the Canadian Arthritis Network (CAN), The Arthritis Society and the Institute of Musculoskeletal Health and Arthritis to join forces and create the Alliance for the Canadian Arthritis Program (ACAP).

Today, ACAP is a coalition of over 20 stakeholder groups dedicated to fighting the burden of arthritis, encouraging government to dedicate resources to arthritis research and care, and supporting those living with the disease. ACAP offers a forum for arthritis stakeholders to collaborate and strategize on arthritis issues and speak with one voice when addressing public policy makers. Together, the members of ACAP are committed to improving arthritis prevention and care across the country.

CAN continues to provide financial and administrative support to ACAP as it works towards defining a national arthritis strategy for Canada.

Please click here to learn more about ACAP's recent initiatives.

Training

The Network is preparing the next generation of arthritis scientists. The Arthritis Society provides a generous contribution of $500,000 per year for the Network's training programs. The program funds graduate students, postdoctoral fellows and junior faculty who are establishing their research careers, and innovative training programs including national and international training rotations in academia and industry. Trainees also receive support to attend the Network's annual scientific conference and other high profile scientific meetings where they can present their work to audiences of leading scientists in their field.

Disability in the Workplace

Arthritis is a leading cause of disability in Canada. The number of working-age people with arthritis will double by 2020. CAN has created a partnership with the Institute for Work & Health (IWH) to reduce illness and disability in the workplace for individuals with arthritis. IWH is an independent, not-for-profit research organization whose mission is to conduct and share research with workers, labour, employers, clinicians and policy-makers to promote, protect and improve the health of working people.

This initiative will examine the burden of osteoarthritis and inflammatory joint diseases on the workplace. It will also offer an opportunity for cross-training. CAN trainees will be introduced to the methods for studying the economic and social impact of arthritis while IWH students, most of whom are not clinicians, will benefit from contact with clinical sites.

North American Arthritis Research Consortium

CAN has initiated and is leading the establishment of a North American Arthritis Research Consortium to integrate arthritis R&D in Canada and the United States. This initiative involves a partnership with participants in the U.S. including the National Institute of Health, the National Institute of Arthritis, Musculoskeletal and Skin Diseases, the Food and Drug Administration, the Arthritis Foundation and industry. The Canadian participants are The Arthritis Society, the Canadian Institutes of Health Research, the Institute of Musculoskeletal Health and Arthritis, Health Canada and provincial health ministries.

Strategic Research Initiative in Osteoarthritis

Three million Canadians have osteoarthritis (OA) and the number is increasing. The Canadian Arthritis Network, the Canadian Institutes of Health Research's (CIHR) Institute of Musculoskeletal Health and Arthritis (IMHA) and The Arthritis Society recognized the urgency of finding the cause and a cure for OA. They organized the Osteoarthritis Consensus conference in the spring of 2002 that brought together leading arthritis researchers, consumers, the pharmaceutical industry, government and international partners, to identify areas where research would be most valuable.

CAN entered into a partnership with IMHA to make $5.5 million available for research under CIHR's New Emerging Team (NET) program in the area of osteoarthritis. The program is building research capacity in OA, building new research teams and giving researchers a building block for applying for research funding in the future.

Three grants were awarded under this program through a peer-review process:

  • Dr. John Esdaile of the Arthritis Research Centre of Canada in Vancouver is developing tools to detect OA at an earlier stage than it is currently diagnosed. This will make early intervention possible, which limits the consequences of the disease.
  • Dr. Gillian Hawker of Sunnybrook and Women's College Health Sciences Centre in Toronto is looking at the determinants and consequences of pain and fatigue in OA using a biopsychosocial approach.
  • Dr. James Henry of McMaster University in Hamilton is looking at the molecular mechanisms of pain and fatigue in OA in the nervous system and joints.

Strategic Research Initiative in Inflammatory Joint Diseases

Rheumatoid arthritis strikes one Canadian in 100, affecting twice as many women as men. The cause is unknown and it is a disabling disease, characterized by inflammation in the lining of the joints. In May, 2004, a consensus conference called Frontiers in Inflammatory Joint Diseases defined the frontiers of research in inflammatory joint disease (IJD). The outcome of the conference was the establishment of research priorities for IJD.

CAN formed a partnership with The Arthritis Society and the Canadian Institutes of Health Research's Institute of Musculoskeletal Health and Arthritis and its Institute of Infection and Immunity to make $5.75 million available for research through the National Research Partnership in IJD. Research proposals under this program require a cash contribution of at least 25 per cent per annum from an outside partner. Funding of successful applications for research proposals will begin in June, 2006.

Return To Top

    © 2007 Canadian Arthritis Network